UiPath (PATH) CEO Daniel Dines reports 45,000-share Rule 10b5-1 sale

Rhea-AI Filing Summary

UiPath, Inc. CEO, Chairman and director Daniel Dines, who is also a 10% owner, reported selling Class A common stock. On 12/08/2025, he sold 45,000 shares of UiPath Class A common stock at an average price of $19.2135 per share, in an open market sale coded as an "S" transaction. The filing states that these sales were made under a pre-arranged trading plan designed to comply with Rule 10b5-1, which allows insiders to sell shares according to a preset schedule.

After this transaction, Dines beneficially owns 29,198,585 shares of UiPath Class A common stock. The price range for the reported trades was between $19.1500 and $19.4100 per share, and detailed trade breakdowns are available upon request from the company, regulators, or shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
12/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/08/2025		S		45,000(1)	D	$19.2135(2)	29,198,585	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $19.1500 to $19.4100. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UiPath (PATH) report in this Form 4?

UiPath reported that its CEO, Chairman and director Daniel Dines sold 45,000 shares of Class A common stock on 12/08/2025 in an open market sale.

At what price did Daniel Dines sell UiPath (PATH) shares?

Daniel Dines sold the 45,000 UiPath Class A shares at an average price of $19.2135 per share, with a reported trade price range of $19.1500 to $19.4100.

How many UiPath (PATH) shares does Daniel Dines own after the sale?

Following the reported transaction, Daniel Dines beneficially owns 29,198,585 shares of UiPath Class A common stock.

Was the UiPath (PATH) insider sale under a Rule 10b5-1 trading plan?

Yes. The filing states the 45,000-share sale was made under a qualified selling plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.

What is the transaction code used in this UiPath (PATH) Form 4?

The transaction is coded as "S" in Table I, indicating an open market or private sale of non-derivative securities.

Who signed the UiPath (PATH) Form 4 for this insider transaction?

The Form 4 was signed by /s/ Brad Brubaker, Attorney-in-Fact, on 12/08/2025 on behalf of the reporting person.